- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Microfluidics specialist Dolomite will be showcasing two groundbreaking devices, Telos and Mitos Dropix, on booth #6 at the 17th International Systems for Chemistry and Life Sciences (MicroTAS) in Freiburg, Germany, from the 27th to the 31st October.
The innovative Telos System is a breakthrough product for a wide range of industries requiring a microfluidic device capable of high throughput droplet, particle and flow product generation. This modular, scalable, and highly flexible technology removes the low throughput limitation of individual microfluidic chips, enabling liters of droplets or particles to be produced in a day. Each module accommodates a microfluidic chip with up to seven channels and, for maximum throughput, up to 10 modules can be linked to provide a total of 70 parallel channels; with tool-free module assembly and chip connection, set-up is rapid. Telos features integrated valves for rapid start-up and individual chip control, and operates over a wide range of pressures and temperatures, from 0 to 10bar and 4 to 50°C, providing users with maximum flexibility.
The novel Mitos Dropix, developed in collaboration with the winner of Dolomite's Productizing Science® Competition 2012, Drop-Tech Ltd, is a flexible, automated solution for droplet-on-demand applications. Patented droplet ‘picking' technology enables combinatorial droplet arrays to be created from multiple reagents off-chip and introduced into a flow-through microfluidic system, with accurate control of droplet size and frequency achieved via PC software. This new high throughput screening format will prove an invaluable resource for basic research, drug discovery, cell-based studies and diagnostics applications.
For more information, visit Dolomite on booth #6 at MicroTAS in Freiburg, or go to www.dolomite-microfluidics.com.
About The Dolomite Centre Ltd
Established in 2005 as the world’s first Microfluidic Application Centre, Dolomite focused on working with customers to turn their concepts for microfluidic applications into reality. Today, Dolomite is the world leader in solving microfluidic problems. With offices in the UK and US and distributors throughout the rest of the world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of chemical, life sciences and clinical diagnostics systems.
Dolomite is pioneering the use of microfluidic devices for small-scale fluid control and analysis, enabling manufacturers to develop more compact, cost-effective and powerful instruments. By combining specialist glass, quartz and ceramic technologies with knowledge of high performance microfluidics, Dolomite is able to provide solutions for a broad range of application areas including environmental monitoring, clinical diagnostics, food and beverage, nuclear, agriculture, petrochemical, cosmetics, pharmaceuticals and chemicals. Furthermore Dolomite's in-house micro-fabrication facilities that include clean rooms and precision glass processing facilities allow to prototype and test all solutions rapidly which ensures a faster development cycle and reduces the time to market.
For more information, please click here
Unit 1, Anglian Business Park, Orchard Road
Royston, Hertfordshire, SG8 5TW, UK
T: +44 (0)1763 242491
F: +44 (0)1763 246125
Copyright © The Dolomite Centre LtdIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Microfluidic devices gently rotate small organisms and cells March 24th, 2016
New microwave imaging approach opens a nanoscale view on processes in liquids: Technique can explore technologically and medically important processes that occur at boundaries between liquids and solids, such as in batteries or along cell membranes March 16th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016